share_log

The Oncology Institute, Inc. (NASDAQ:TOIIW) COO Matthew P. Miller Buys 73,684 Shares of Stock

The Oncology Institute, Inc. (NASDAQ:TOIIW) COO Matthew P. Miller Buys 73,684 Shares of Stock

肿瘤学研究所有限公司(纳斯达克股票代码:TOIIW)首席运营官马修·米勒购买了73,684股股票
Defense World ·  2022/12/21 06:31

The Oncology Institute, Inc. (NASDAQ:TOIIW – Get Rating) COO Matthew P. Miller bought 73,684 shares of Oncology Institute stock in a transaction on Friday, December 16th. The stock was acquired at an average cost of $0.95 per share, with a total value of $69,999.80. Following the acquisition, the chief operating officer now owns 175,325 shares in the company, valued at approximately $166,558.75. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

肿瘤研究所,公司(纳斯达克:TOIIW-GET评级)首席运营官马修·P·米勒在12月16日星期五的一笔交易中购买了73,684股肿瘤研究所的股票。该股是以每股0.95美元的平均成本收购的,总价值为69,999.80美元。收购完成后,首席运营官现在拥有该公司175,325股股票,价值约166,558.75美元。此次收购是在提交给美国证券交易委员会的一份文件中披露的,该文件可通过这个环节.

Oncology Institute Stock Performance

肿瘤研究所股票表现

TOIIW stock opened at $0.06 on Wednesday. The Oncology Institute, Inc. has a 1 year low of $0.06 and a 1 year high of $1.50. The stock's fifty day moving average price is $0.32 and its 200-day moving average price is $0.56.

周三,TOIIW股价开盘报0.06美元。肿瘤学研究所,Inc.的一年低点为0.06美元,一年高位为1.50美元。该股的50日移动均线价格为0.32美元,200日移动均线价格为0.56美元。

Get
到达
Oncology Institute
肿瘤学研究所
alerts:
警报:

Hedge Funds Weigh In On Oncology Institute

对冲基金参与肿瘤学研究所

A hedge fund recently raised its stake in Oncology Institute stock. Wolverine Asset Management LLC boosted its stake in shares of The Oncology Institute, Inc. (NASDAQ:TOIIW – Get Rating) by 29.0% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 118,666 shares of the company's stock after acquiring an additional 26,700 shares during the quarter. Wolverine Asset Management LLC's holdings in Oncology Institute were worth $59,000 as of its most recent SEC filing.

一家对冲基金最近增持了肿瘤学研究所的股票。金刚狼资产管理有限责任公司根据其向美国证券交易委员会(美国证券交易委员会)披露的最新信息,在第二季度将其在肿瘤研究所公司(美国证券交易委员会:TOIIW-GET评级)的股份增加了29.0%。该基金在本季度增持了26,700股后,持有118,666股该公司股票。截至最近提交的美国证券交易委员会申报文件,金刚狼资产管理有限公司持有的肿瘤学研究所股份价值59,000美元。

About Oncology Institute

关于肿瘤学研究所

(Get Rating)
(获取评级)

The Oncology Institute, Inc, an oncology company, provides medical oncology services in the United States. Its services include physician services, in-house infusion and dispensary, clinical trial services, outpatient stem cell transplants and transfusions programs, and patient support. The company also offers and manages clinical trial services, such as managing clinical trials, palliative care programs, and stem cell transplants for cancer patients.

肿瘤学研究所是一家肿瘤学公司,在美国提供内科肿瘤学服务。它的服务包括医生服务、内部输液和药房、临床试验服务、门诊干细胞移植和输血计划以及患者支持。该公司还提供和管理临床试验服务,如管理临床试验、姑息治疗计划和癌症患者的干细胞移植。

Recommended Stories

推荐故事

  • Get a free copy of the StockNews.com research report on Oncology Institute (TOIIW)
  • Is There a Prize in Store for Kellogg Shareholders?
  • Will AMC's Troubles Affect Its Landlord, EPR Properties?
  • General Mills Retreats To More Attractive Territory
  • Will Tesla Shares Rally If Musk Steps Down From Twitter?
  • 5 Down But Not Out Stocks To Watch For 2023
  • 免费获取StockNews.com肿瘤学研究所研究报告(TOIIW)
  • 凯洛格的股东有店内奖品吗?
  • AMC的麻烦会影响其房东EPR Properties吗?
  • 通用磨坊撤退至更具吸引力的地区
  • 如果马斯克退出Twitter,特斯拉的股价会上涨吗?
  • 2023年值得关注的5个下跌但不是下跌的股票

Receive News & Ratings for Oncology Institute Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oncology Institute and related companies with MarketBeat.com's FREE daily email newsletter.

接受肿瘤学研究所每日新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收肿瘤学研究所和相关公司的最新新闻和分析师评级的每日简明摘要。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发